The DOI matches its Crossref record; 101 of the 101 references it cites were found in a registry or an index.
Transporter-Guided Delivery of Nanoparticles to Improve Drug Permeation across Cellular Barriers and Drug Exposure to Selective Cell Types
Open accessAbstract
Targeted nano-drug delivery systems conjugated with specific ligands to target selective cell-surface receptors or transporters could enhance the efficacy of drug delivery and therapy. Transporters are expressed differentially on the cell-surface of different cell types, and also specific transporters are expressed at higher than normal levels in selective cell types under pathological conditions. They also play a key role in intestinal absorption, delivery via non-oral routes (e.g., pulmonary route and nasal route), and transfer across biological barriers (e.g., blood-brain barrier and blood-retinal barrier. As such, the cell-surface transporters represent ideal targets for nano-drug delivery systems to facilitate drug delivery to selective cell types under normal or pathological conditions and also to avoid off-target adverse side effects of the drugs. There is increasing evidence in recent years supporting the utility of cell-surface transporters in the field of nano-drug delivery to increase oral bioavailability, to improve transfer across the blood-brain barrier, and to enhance delivery of therapeutics in a cell-type selective manner in disease states. Here we provide a comprehensive review of recent advancements in this interesting and important area. We also highlight certain key aspects that need to be taken into account for optimal development of transporter-assisted nano-drug delivery systems.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Membrane transporters in drug development
The International Transporter Consortium, Giacomini, K. M., Huang, S.-M., Tweedie, D. J., Benet, L. Z., Brouwer, K. L. R., Chu, X., Dahlin, A., Evers, R., Fischer, V., et al. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3028 · Cited by 3,340
Sahay, G., Alakhova, D. Y., & Kabanov, A. V. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.01.036 · Cited by 2,181
Uptake Pathways and Subsequent Intracellular Trafficking in Nonviral Gene Delivery
Khalil, I. A., Kogure, K., Akita, H., & Harashima, H. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.1.8 · Cited by 1,240
Kanai, Y., Segawa, H., Miyamoto, K.-I., Uchino, H., Takeda, E., & Endou, H. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.37.23629 · Cited by 1,109
Glucose transporters (GLUT and SGLT): expanded families of sugar transport proteins
Wood, I. S., & Trayhurn, P. (2003) · British Journal of Nutrition · doi:10.1079/bjn2002763 · Cited by 889
Bile Acids: Chemistry, Pathochemistry, Biology, Pathobiology, and Therapeutics
Hofmann, A. F., & Hagey, L. R. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-7568-6 · Cited by 859
Targeting brain cancer: advances in the molecular pathology of malignant glioma and medulloblastoma
Huse, J. T., & Holland, E. C. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2818 · Cited by 763
Yanagida, O., Kanai, Y., Chairoungdua, A., Kim, D. K., Segawa, H., Nii, T., Cha, S. H., Matsuo, H., Fukushima, J.-I., Fukasawa, Y., et al. (2001) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(01)00384-4 · Cited by 746
Local Actin Polymerization and Dynamin Recruitment in SV40-Induced Internalization of Caveolae
Pelkmans, L., Püntener, D., & Helenius, A. (2002) · Science · doi:10.1126/science.1069784 · Cited by 720
Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers
Gu, F., Zhang, L., Teply, B. A., Mann, N., Wang, A., Radovic-Moreno, A. F., Langer, R., & Farokhzad, O. C. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711714105 · Cited by 715
Tamai, I., Ohashi, R., Nezu, J.-I., Yabuuchi, H., Oku, A., Shimane, M., Sai, Y., & Tsuji, A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.32.20378 · Cited by 697
Dawson, P. A., Lan, T., & Rao, A. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r900012-jlr200 · Cited by 680
Blood-brain barrier drug targeting: the future of brain drug development.
Pardridge, W. M. (2003) · Molecular Interventions · doi:10.1124/mi.3.2.90 · Cited by 570
The endocytosis and intracellular fate of nanomedicines: Implication for rational design
Kou, L., Sun, J., Zhai, Y., & He, Z. (2013) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2013.07.001 · Cited by 569
Self-citationNanoparticles for oral delivery: Design, evaluation and state-of-the-art
Date, A. A., Hanes, J., & Ensign, L. M. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.06.016 · Cited by 539
More Effective Nanomedicines through Particle Design
Wang, J., Byrne, J. D., Napier, M. E., & DeSimone, J. M. (2011) · Small · doi:10.1002/smll.201100442 · Cited by 466
Conde, J., Oliva, N., Zhang, Y., & Artzi, N. (2016) · Nature Materials · doi:10.1038/nmat4707 · Cited by 449
Yun, Y., Cho, Y. W., & Park, K. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.10.007 · Cited by 444
Effect of ligand density, receptor density, and nanoparticle size on cell targeting
Elias, D. R., Poloukhtine, A., Popik, V., & Tsourkas, A. (2013) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2012.05.015 · Cited by 404
CARNITINE METABOLISM AND ITS REGULATION IN MICROORGANISMS AND MAMMALS
Rebouche, C. J., & Seim, H. (1998) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.18.1.39 · Cited by 362 · cited 1×
“L-Carnitine can be synthesized from lysine endogenously, but a majority of L-carnitine in the body is from intestinal absorption of dietary L-carnitine (Rebouche and Seim, 1998).”
BackgroundTransport of Valganciclovir, a Ganciclovir Prodrug, via Peptide Transporters PEPT1 and PEPT2
Sugawara, M., Huang, W., Fei, Y., Leibach, F. H., Ganapathy, V., & Ganapathy, M. E. (2000) · Journal of Pharmaceutical Sciences · doi:10.1002/(sici)1520-6017(200006)89:6<781::aid-jps10>3.0.co;2-7 · Cited by 312
Self-citationValacyclovir: A Substrate for the Intestinal and Renal Peptide Transporters PEPT1 and PEPT2
Ganapathy, M. E., Huang, W. Y., Wang, H., Ganapathy, V., & Leibach, F. H. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8628 · Cited by 301
Self-citationDelivery of molecularly targeted therapy to malignant glioma, a disease of the whole brain
Agarwal, S., Sane, R., Oberoi, R., Ohlfest, J. R., & Elmquist, W. F. (2011) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399411001888 · Cited by 292
Targeting cancer cells with biotin–dendrimer conjugates
Yang, W., Cheng, Y., Xu, T., Wang, X., & Wen, L.-P. (2009) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2008.04.021 · Cited by 290
Jiang, X., Xin, H., Ren, Q., Gu, J., Zhu, L., Du, F., Feng, C., Xie, Y., Sha, X., & Fang, X. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2013.09.094 · Cited by 270
Crystal structure of a bacterial homologue of the bile acid sodium symporter ASBT
Hu, N.-J., Iwata, S., Cameron, A. D., & Drew, D. (2011) · Nature · doi:10.1038/nature10450 · Cited by 266
Rao, A., Haywood, J., Craddock, A. L., Belinsky, M. G., Kruh, G. D., & Dawson, P. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712328105 · Cited by 225
Biotinylated liposomes as potential carriers for the oral delivery of insulin
Zhang, X., Qi, J., Lu, Y., He, W., Li, X., & Wu, W. (2014) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2013.07.011 · Cited by 194
Vascular Targeting of Nanocarriers: Perplexing Aspects of the Seemingly Straightforward Paradigm
Howard, M., Zern, B. J., Anselmo, A. C., Shuvaev, V. V., Mitragotri, S., & Muzykantov, V. (2014) · ACS Nano · doi:10.1021/nn500136z · Cited by 192
Focusing on clathrin-mediated endocytosis.
Rappoport, J. Z. (2008) · Biochemical Journal · doi:10.1042/bj20080474 · Cited by 172
Kido, Y., Tamai, I., Ohnari, A., Sai, Y., Kagami, T., Nezu, J., Nikaido, H., Hashimoto, N., Asano, M., & Tsuji, A. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00621.x · Cited by 169
Targeted nanoparticles with novel non-peptidic ligands for oral delivery
Rieux, A. D., Pourcelle, V., Cani, P. D., Marchand‐Brynaert, J., & Véronique Préat, A. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.01.002 · Cited by 159
The sodium-dependent ascorbic acid transporter family SLC23
Bürzle, M., Suzuki, Y., Ackermann, D., Miyazaki, H., Maeda, N., Clémençon, B., Burrier, R., & Hediger, M. A. (2013) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.12.002 · Cited by 158
Yang, H., Chen, Y., Chen, Z., Geng, Y., Xie, X., Shen, X., Li, T., Li, S., Wu, C., & Liu, Y. (2017) · Biomaterials Science · doi:10.1039/c7bm00043j · Cited by 153
Cundy, K. C., Branch, R., Chernov-Rogan, T., et al. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.067934 · Cited by 152
Xie, F., Xie, F., Qin, Yuan, Tang, Zhang, Fan, Chen, Hai, Yao, et al. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s23771 · Cited by 142
Tamai, I. (2013) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.1816 · Cited by 141
Gong, Y., Everett, E. T., Schwartz, D. A., Norris, J. S., & Wilson, F. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.11.4741 · Cited by 136
Gupta, N., Miyauchi, S., Martindale, R. G., Herdman, A. V., Podolsky, R. H., Miyake, K., Mager, S., Prasad, P. D., Ganapathy, M. E., & Ganapathy, V. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2005.04.002 · Cited by 136
Self-citationKarunakaran, S. K., Umapathy, N. S., Thangaraju, M., Hatanaka, T., Itagaki, S., Munn, D. H., Prasad, P. D., & Ganapathy, V. (2008) · Biochemical Journal · doi:10.1042/bj20080622 · Cited by 125
Self-citationCholine transporter-targeting and co-delivery system for glioma therapy
Li, J., Guo, Y., Kuang, Y., An, S., Ma, H., & Jiang, C. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.08.030 · Cited by 122
Minko, T., Paranjpe, P. V., Qiu, B., Lalloo, A., Won, R., Stein, S., & Sinko, P. J. (2002) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-002-0463-1 · Cited by 120
SLC transporters as a novel class of tumour suppressors: identity, function and molecular mechanisms
Bhutia, Y. D., Babu, E., Ramachandran, S., Yang, S., Thangaraju, M., & Ganapathy, V. (2016) · Biochemical Journal · doi:10.1042/bj20150751 · Cited by 119
Self-citationLee, Y.-K., Nam, J. H., Shin, H., & Byun, Y. (2001) · Circulation · doi:10.1161/hc5001.100627 · Cited by 115
Li, L., Di, X., Zhang, S., Kan, Q., Liu, H., Lu, T., Wang, Y., Fu, Q., Sun, J., & He, Z. (2016) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2016.01.041 · Cited by 115
Self-citationOCTN Cation Transporters in Health and Disease: Role as Drug Targets and Assay Development
Pochini, L., Scalise, M., Galluccio, M., & Indiveri, C. (2013) · SLAS DISCOVERY · doi:10.1177/1087057113493006 · Cited by 113
Up-regulation of the amino acid transporter ATB0,+ (SLC6A14) in carcinoma of the cervix
Gupta, N., Prasad, P. D., Ghamande, S. A., Martin, P. M., Herdman, A. V., Martindale, R. G., Podolsky, R. H., Mager, S., Ganapathy, M. E., & Ganapathy, V. (2005) · Gynecologic Oncology · doi:10.1016/j.ygyno.2005.08.016 · Cited by 109
Self-citationDrug delivery strategies for the treatment of malignant gliomas
Allhenn, D., Boushehri, M. A. S., & Lamprecht, A. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.06.025 · Cited by 106
Zern, B. J., Chacko, A., Liu, J., Greineder, C. F., Blankemeyer, E. R., Radhakrishnan, R., & Muzykantov, V. R. (2013) · ACS Nano · doi:10.1021/nn305773f · Cited by 105
Transporter-Mediated Drug Uptake and Efflux: Important Determinants of Adverse Drug Reactions
Zolk, O., & Fromm, M. F. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2010.354 · Cited by 101
Yellepeddi, V., Kumar, A., & Palakurthi, S. (2009) · PubMed · Cited by 100
Controlling Ligand Surface Density Optimizes Nanoparticle Binding to ICAM-1
Fakhari, A., Baoum, A. A., Siahaan, T. J., Le, K. B., & Berkland, C. J. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22342 · Cited by 97
Improving Tumor Specificity and Anticancer Activity of Dasatinib by Dual-Targeted Polymeric Micelles
Yao, Q., Choi, J. H., Dai, Z., Wang, J., Kim, D., Tang, X., & Zhu, L. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b12233 · Cited by 95
Self-citationYellepeddi, V., Kumar, A., Maher, D. M., Chauhan, S. C., Vangara, K. K., & Palakurthi, S. (2011) · PubMed · Cited by 93
Kou, L., Hou, Y., Yao, Q., Guo, W., Wang, G., Wang, M., Fu, Q., He, Z., Ganapathy, V., & Sun, J. (2017) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2017.1384385 · Cited by 93
Self-citationLuo, F., Liu, X., Yan, N., Li, S., Cao, G., Cheng, Q., Xia, Q., & Wang, H. (2006) · BMC Cancer · doi:10.1186/1471-2407-6-26 · Cited by 91
Kou, L., Yao, Q., Sivaprakasam, S., Luo, Q., Sun, Y. H., Fu, Q., He, Z., Sun, J., & Ganapathy, V. (2017) · Drug Delivery · doi:10.1080/10717544.2017.1377316 · Cited by 89
Self-citationThe blood-brain barrier choline transporter as a brain drug delivery vector
Allen, D. D., & Lockman, P. R. (2003) · Life Sciences · doi:10.1016/s0024-3205(03)00504-6 · Cited by 86
Shao, K., Ding, N., Huang, S., Ren, S., Zhang, Y. X., Kuang, Y., Guo, Y., Ma, H., An, S., Li, Y., et al. (2014) · ACS Nano · doi:10.1021/nn406285x · Cited by 86
Synthesis and Biological Properties of Insulin−Deoxycholic Acid Chemical Conjugates
Lee, S., Kim, K., Kumar, T. S., Lee, J. S., Kim, S. K., Lee, D. Y., Lee, Y.-K., & Byun, Y. (2005) · Bioconjugate Chemistry · doi:10.1021/bc049871e · Cited by 85
Li, L., Di, X., Wu, M., Sun, Z., Zhong, L., Wang, Y., Fu, Q., Kan, Q., Sun, J., & He, Z. (2016) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2016.11.012 · Cited by 84
Self-citationSynthesis and evaluation of biotin-conjugated pH-responsive polymeric micelles as drug carriers
Kim, J. H., Li, Y., Kim, M.-S., Kang, S. W., Jeong, J. H., & Lee, D. S. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.01.034 · Cited by 83
Choline‐Derivate‐Modified Nanoparticles for Brain‐Targeting Gene Delivery
Li, J., Zhou, L., Ye, D., Huang, S., Shao, K., Huang, R., Han, L., Liu, Y., Liu, S., Ye, L., et al. (2011) · Advanced Materials · doi:10.1002/adma.201101899 · Cited by 83
The amino acid transporter SLC6A14 in cancer and its potential use in chemotherapy
Bhutia, Y. D., Babu, E., Prasad, P. D., & Ganapathy, V. (2014) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2014.04.004 · Cited by 83
Self-citationInano, A., Sai, Y., Nikaido, H., Hashimoto, N., Asano, M., Tsuji, A., & Tamai, I. (2003) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.371 · Cited by 81
Aleandri, S., Bandera, D., Mezzenga, R., & Landau, E. M. (2015) · Langmuir · doi:10.1021/acs.langmuir.5b03469 · Cited by 81
Kou, L., Yao, Q., Sun, M., Wu, C., Wang, J., Luo, Q., Wang, G., Du, Y., Fu, Q., Wang, J., et al. (2017) · Advanced Healthcare Materials · doi:10.1002/adhm.201700165 · Cited by 80
Self-citationZhou, X., Zhang, X., Ye, Y., Zhang, T., Wang, H., Ma, Z., & Wu, B. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.12.068 · Cited by 75
Oral delivery of taurocholic acid linked heparin–docetaxel conjugates for cancer therapy
Khatun, Z., Nurunnabi, M., Reeck, G. R., Cho, K.-J., & Lee, Y.-K. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.04.024 · Cited by 74
Venishetty, V. K., Samala, R., Komuravelli, R., Kuncha, M., Sistla, R., & Diwan, P. V. (2012) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2012.08.004 · Cited by 73
Amino Acid Transporter ATB0,+ as a Delivery System for Drugs and Prodrugs
Ganapathy, M. E., & Ganapathy, V. (2005) · Current Drug Targets - Immune Endocrine & Metabolic Disorders · doi:10.2174/156800805774912953 · Cited by 73
Self-citationMiecz, D., Januszewicz, E., Czeredys, M., Hinton, B. T., Bérézowski, V., Cecchelli, R., & Nałęcz, K. A. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05024.x · Cited by 72
Yao, Q., Dai, Z., Hoon Choi, J., Kim, D., & Zhu, L. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b09511 · Cited by 71
Self-citationMMP2-Sensitive PEG–Lipid Copolymers: A New Type of Tumor-Targeted P-Glycoprotein Inhibitor
Dai, Z., Yao, Q., & Zhu, L. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b03064 · Cited by 71
Self-citationCholine Derivate-Modified Doxorubicin Loaded Micelle for Glioma Therapy
Li, J., Yang, H., Zhang, Y., Jiang, X., Guo, Y., An, S., Ma, H., He, X., & Jiang, C. (2015) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5b07045 · Cited by 63
Functional transformations of bile acid transporters induced by high-affinity macromolecules
Al-Hilal, T. A., Chung, S. W., Alam, F., Park, J., Lee, K. E., Jeon, H., Kim, K., Kwon, I. C., Kim, I.-S., Kim, S. Y., et al. (2014) · Scientific Reports · doi:10.1038/srep04163 · Cited by 59
Oligomeric bile acid-mediated oral delivery of low molecular weight heparin
Al-Hilal, T. A., Park, J., Alam, F., Chung, S. W., Park, J. W., Kim, K., Kwon, I. C., Kim, I.-S., Kim, S. Y., & Byun, Y. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.12.001 · Cited by 57
Xiong, F., Zhu, Z., Chen, X., Hua, X., Shan, X., Zhang, Y., & Gu, N. (2011) · Pharmaceutical Research · doi:10.1007/s11095-011-0653-9 · Cited by 54
Alam, F., Al-Hilal, T. A., Chung, S. W., Seo, D.-H., Mahmud, F., Kim, H. S., Kim, S. Y., & Byun, Y. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.04.050 · Cited by 51
Luo, Q., Gong, P., Sun, M., Kou, L., Ganapathy, V., Jing, Y., He, Z., & Sun, J. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.10.031 · Cited by 50
Self-citationLAT1-mediated Prodrug Uptake: a Way to Breach the blood–brain barrier?
Rautio, J., Gynther, M., & Laine, K. (2013) · Therapeutic Delivery · doi:10.4155/tde.12.165 · Cited by 49
van der Velden, L. M., Golynskiy, M. V., Bijsmans, I. T. G. W., van Mil, S. W. C., Klomp, L. W. J., Merkx, M., & van de Graaf, S. F. J. (2012) · Hepatology · doi:10.1002/hep.26012 · Cited by 48
Biotin uptake by human proximal tubular epithelial cells: cellular and molecular aspects
Balamurugan, K., Vaziri, N. D., & Said, H. M. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00375.2004 · Cited by 47
Uptake and transport of B 12 -conjugated nanoparticles in airway epithelium
Fowler, R., Vllasaliu, D., Falcone, F. H., Garnett, M. C., Smith, B., Horsley, H. T., Alexander, C., & Stolnik, S. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.08.028 · Cited by 47
Targeting Glioma Cells in Vitro with Ascorbate-Conjugated Pharmaceutical Nanocarriers
Salmaso, S., Pappalardo, J. S., Sawant, R. R., Musacchio, T., Rockwell, K. R., Caliceti, P., & Torchilin, V. P. (2009) · Bioconjugate Chemistry · doi:10.1021/bc900369d · Cited by 46
Lee, S., Lee, J., Lee, D. Y., Kim, S., Lee, Y.-J., & Byun, Y. (2005) · Diabetologia · doi:10.1007/s00125-004-1658-2 · Cited by 44
Targeting Glut1-overexpressing MDA-MB-231 cells with 2-deoxy-d-g1ucose modified SPIOs
Shan, X. H., Hu, H., Xiong, F., Gu, N., Geng, X. D., Zhu, W., Lin, J., & Wang, Y. F. (2011) · European Journal of Radiology · doi:10.1016/j.ejrad.2011.03.013 · Cited by 43
Phenylalanine-coupled solid lipid nanoparticles for brain tumor targeting
Kharya, P., Jain, A., Gulbake, A., Shilpi, S., Jain, A., Hurkat, P., Majumdar, S., & Jain, S. (2013) · Journal of Nanoparticle Research · doi:10.1007/s11051-013-2022-6 · Cited by 43
Luo, Q., Yang, B., Tao, W., Li, J., Kou, L., Lian, H., Che, X., He, Z., & Sun, J. (2016) · Biomaterials Science · doi:10.1039/c6bm00788k · Cited by 43
Self-citationBérézowski, V., Miecz, D., Marszałek, M., Bröer, A., Bröer, S., Cecchelli, R., & Nałęcz, K. A. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02752.x · Cited by 37
Geldenhuys, W. J., Lockman, P. R., Nguyen, T. H., der Schyf, C. J. V., Crooks, P. A., Dwoskin, L. P., & Allen, D. D. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.04.020 · Cited by 34
Jiang, X., Xin, H., Gu, J., Du, F., Feng, C., Xie, Y., & Fang, X. (2014) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23928 · Cited by 31
A choline derivate-modified nanoprobe for glioma diagnosis using MRI
Li, J., Huang, S., Shao, K., Liu, Y., An, S., Kuang, Y., Guo, Y., Ma, H., Wang, X., & Jiang, C. (2013) · Scientific Reports · doi:10.1038/srep01623 · Cited by 29
DNA-Binding Properties of Poly(ADP-Ribose) Polymerase: A Target for Anti-Cancer Therapy
Солдатенков, В. А., & Potaman, V. N. (2004) · Current Drug Targets · doi:10.2174/1389450043345498 · Cited by 27
Mechanisms of Biotin Transport
Polyak, S. W. (2015) · Biochemistry & Analytical Biochemistry · doi:10.4172/2161-1009.1000210 · Cited by 23
Morral-Ruíz, G., Melgar‐Lesmes, P., López-Vicente, A., Solans, C., & García, M. J. N. (2015) · Nano Research · doi:10.1007/s12274-014-0678-6 · Cited by 20
Insulin-based regulation of glucose-functionalized nanoparticle uptake in muscle cells
Yeh, Y., Kim, S. T., Tang, R., Yan, B., & Rotello, V. M. (2014) · Journal of Materials Chemistry B · doi:10.1039/c4tb00608a · Cited by 19
P‐Glycoprotein‐Dependent Trafficking of Nanoparticle‐Drug Conjugates
Dreaden, E. C., Raji, I. O., Austin, L. A., Fathi, S., Mwakwari, S. C., Humphries, W. H., Kang, B., Oyelere, A. K., & El‐Sayed, M. A. (2014) · Small · doi:10.1002/smll.201303190 · Cited by 18
Park, J., Al-Hilal, T. A., Jeong, J., Choi, J. U., & Byun, Y. (2015) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.5b00230 · Cited by 15
Drug Transporters: Recent Advances and Therapeutic Applications
Franke, R. M., & Sparreboom, A. (2009) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.239 · Cited by 12
Hu, J.-L., Hu, X.-L., Han, Q., Guo, A.-Y., Wang, C.-J., Wen, Y.-Y., & Cang, S. D. (2017) · Gene Therapy · doi:10.1038/gt.2017.26 · Cited by 6
Cited by
Engineering precision nanoparticles for drug delivery
Mitchell, M. J., Billingsley, M. M., Haley, R. M., Wechsler, M. E., Peppas, N. A., & Langer, R. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0090-8 · Cited by 7,933
Evaluation of intranasal delivery route of drug administration for brain targeting
Erdő, F., Bors, L. A., Farkas, D., Bajza, Á., & Gizurarson, S. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2018.10.009 · Cited by 744
Current hurdles to the translation of nanomedicines from bench to the clinic
Đorđević, S., Gonzalez, M. M., Conejos-Sánchez, I., Carreira, B., Pozzi, S., Acúrcio, R. C., Satchi-Fainaro, R., Florindo, H. F., & Vicent, M. J. (2022) · Drug Delivery and Translational Research · doi:10.1007/s13346-021-01024-2 · Cited by 657
Abbasi, R., Shineh, G., Mobaraki, M., Doughty, S., & Tayebi, L. (2023) · Journal of Nanoparticle Research · doi:10.1007/s11051-023-05690-w · Cited by 623
Brown, T. P., & Ganapathy, V. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.107451 · Cited by 481
Self-citation
Metadata
- Authors
- Kou, L., Bhutia, Y. D., Yao, Q., He, Z., Sun, J., & Ganapathy, V.
- Venue
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Published
- 2018-01-26
- Volume
- 9
- Pages
- 27-27
- ISSN
- 1663-9812 (ISSN-L)
- OpenAlex
- W2792971737
- Cited by
- 308
- References
- 101
- FWCI
- 6.68
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.